SEC Filing Details

Our enduring purpose: to fundamentally improve the lives of patients with serious diseases in ways never before possible.

SEC Filing Details

Document Details

Form
Filing Date
Feb 6, 2020
Document Date
Feb 5, 2020
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Five Prime Therapeutics
Issuer
FIVE PRIME THERAPEUTICS, INC.
Filer
Collins Helen Louise